{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:47:39Z","timestamp":1775051259857,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The central role of microbiota and the contribution of diet in immune-mediated inflammatory diseases (IMID) are increasingly examined. However, patients\u2019 perspectives on nutrition and its impact on their disease has not received a lot of attention. We aimed to directly collect information from patients with IMID about their dietary behaviors and their perceptions of the influence of nutrition on their disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn\u2019s disease, ulcerative colitis or psoriasis registered in an online patient community were invited to participate in the study and complete an online self-administered questionnaire. We assessed patients\u2019 dietary knowledge and choices by collecting information on the diet regimens they were following or recommended and their perceptions of the diet and its consequences on their disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty patients per target disease were included with a mean age of 48.1\u2009years (95%CI 46.7\u201349.6). Other sociodemographic and clinical characteristics varied across the diseases. Since diagnosis, 44% of the patients changed their eating habits, mainly patients with inflammatory bowel disease with 69% of these making the change on their own initiative. Patients who did not change their diet habits reported not having received nutritional advice from their healthcare professionals (HCP) in 69% of the cases. The perceived impact of nutrition on their symptoms was mixed (overall 74% of the patients reported positive consequences and 60% negative ones) and varied across the diseases. Patients with psoriasis only experienced positive consequences from changing their diet, such as reduction of stress and improved mental health, while patients with Crohn\u2019s disease reported more negative effects such as increased fatigue and disturbed sleep. Patients with rheumatic diseases and ulcerative colitis reported weight loss and better physical fitness, but also increased fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Even if differences exist across diseases, the importance of nutrition and its potential positive role in symptom management is acknowledged by the majority of the patients. However, there is a need and a demand from patients to receive more dietary advice. Developing therapeutic education tools on nutrition for people with IMID and involving patients\u2019 organizations would provide useful information and encourage communication between HCP and patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40795-021-00446-y","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:05:46Z","timestamp":1626375946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune-mediated inflammatory diseases and nutrition: results from an online survey on patients\u2019 practices and perceptions"],"prefix":"10.1186","volume":"7","author":[{"given":"Thao","family":"Pham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Halioua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Pourcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Pain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"446_CR1","unstructured":"American Autoimmune Related Diseases Association. Autoimmune diseases list. Available from: https:\/\/www.aarda.org\/diseaselist\/. Accessed Oct 2019."},{"key":"446_CR2","unstructured":"Meccain J. The Disease Burden of the Most Common Autoimmune Diseases. Manag Care 2016; 25(7): 28\u201332. Available from: https:\/\/www.managedcaremag.com\/archives\/2016\/7\/disease-burden-most-common-autoimmune-diseases. Accessed Oct 2019."},{"issue":"1","key":"446_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/reum.2018.74750","volume":"56","author":"M Olesi\u0144ska","year":"2018","unstructured":"Olesi\u0144ska M, Saletra A. Quality of life in systemic lupus erythematosus and its measurement. Reumatologia. 2018;56(1):45\u201354. Available from. https:\/\/doi.org\/10.5114\/reum.2018.74750.","journal-title":"Reumatologia"},{"issue":"12","key":"446_CR4","doi-asserted-by":"publisher","first-page":"e0189840","DOI":"10.1371\/journal.pone.0189840","volume":"12","author":"J Greenfield","year":"2017","unstructured":"Greenfield J, Hudson M, Vinet E, Fortin PR, Bykerk V, Pineau CA, et al. A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs). PLoS One. 2017;12(12):e0189840. Available from. https:\/\/doi.org\/10.1371\/journal.pone.0189840.","journal-title":"PLoS One"},{"issue":"3","key":"446_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2009.02.015","volume":"61","author":"M Makredes","year":"2009","unstructured":"Makredes M, Robinson D Jr, Bala M, Kimball AB. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol. 2009;61(3):405\u201310. Available from. https:\/\/doi.org\/10.1016\/j.jaad.2009.02.015.","journal-title":"J Am Acad Dermatol"},{"key":"446_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369\u201395. Available from. https:\/\/doi.org\/10.1111\/joim.12395.","journal-title":"J Intern Med"},{"issue":"6","key":"446_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/ar3175","volume":"12","author":"JM Anaya","year":"2010","unstructured":"Anaya JM. The autoimmune tautology. Arthritis res Ther. 2010;12(6):147. Available from. https:\/\/doi.org\/10.1186\/ar3175.","journal-title":"Arthritis res Ther"},{"issue":"7","key":"446_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fimmu.2016.00139","volume":"26","author":"JM Anaya","year":"2016","unstructured":"Anaya JM, Ramirez-Santana C, Alzate MA, Molano-Gonzalez N, Rojas-Villarraga A. The Autoimmune Ecology. Front Immunol. 2016;26(7):139. eCollection 2016 Available from. https:\/\/doi.org\/10.3389\/fimmu.2016.00139.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"446_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","volume":"160","author":"P Brodin","year":"2015","unstructured":"Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJ, Furman D, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell. 2015;160(1\u20132):37\u201347. Available from. https:\/\/doi.org\/10.1016\/j.cell.2014.12.020.","journal-title":"Cell"},{"issue":"6","key":"446_CR10","doi-asserted-by":"publisher","first-page":"A249","DOI":"10.1289\/ehp.119-a248","volume":"119","author":"CW Schmidt","year":"2011","unstructured":"Schmidt CW. Questions persist: environmental factors in autoimmune disease. Environ Health Perspect. 2011;119(6):A249\u201353. Available from. https:\/\/doi.org\/10.1289\/ehp.119-a248.","journal-title":"Environ Health Perspect"},{"issue":"6","key":"446_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2014.05.014","volume":"40","author":"AN Thorburn","year":"2014","unstructured":"Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and \u201cwestern-lifestyle\u201d inflammatory diseases. Immunity. 2014;40(6):833\u201342. Available from. https:\/\/doi.org\/10.1016\/j.immuni.2014.05.014.","journal-title":"Immunity"},{"issue":"6","key":"446_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/0961203313501401","volume":"23","author":"SM Vieira","year":"2014","unstructured":"Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus. 2014;23(6):518\u201326. Available from. https:\/\/doi.org\/10.1177\/0961203313501401.","journal-title":"Lupus"},{"key":"446_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2017.01.042","volume":"455","author":"IY Choi","year":"2017","unstructured":"Choi IY, Lee C, Longo VD. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence. Mol Cell Endocrinol. 2017;455:4\u201312. Available from. https:\/\/doi.org\/10.1016\/j.mce.2017.01.042.","journal-title":"Mol Cell Endocrinol"},{"key":"446_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fmed.2018.00141","volume":"5","author":"K Masuko","year":"2018","unstructured":"Masuko K. A Potential Benefit of \u201cBalanced Diet\u201d for Rheumatoid Arthritis. Front Med. 2018;5:141. Available from. https:\/\/doi.org\/10.3389\/fmed.2018.00141.","journal-title":"Front Med"},{"key":"446_CR15","volume-title":"Autoimmune diseases \u2013 modern diseases: report","author":"European Parliament","year":"2017","unstructured":"European Parliament. Autoimmune diseases \u2013 modern diseases: report. 2017. Available from: https:\/\/www.europarl.europa.eu\/cmsdata\/133620\/ENVI%202017-09%20WS%20Autoimmune%20diseases%20%20PE%20614.174%20(Publication).pdf. Accessed Oct 2019."},{"issue":"7","key":"446_CR16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.1700688114","volume":"114","author":"M Scudellari","year":"2017","unstructured":"Scudellari M. Cleaning up the hygiene hypothesis. Proc Natl Acad Sci. 2017;114(7):1433\u20136. Available from. https:\/\/doi.org\/10.1073\/pnas.1700688114.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"446_CR17","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1128\/mSystems.00036-17","volume":"2","author":"T Sharpton","year":"2017","unstructured":"Sharpton T, Lyalina S, Luong J, Pham J, Deal EM, Armour C, et al. Development of inflammatory bowel disease is linked to a longitudinal restructuring of the gut metagenome in mice. mSystems. 2017;2(5):e00036\u201317. Available from. https:\/\/doi.org\/10.1128\/mSystems.00036-17.","journal-title":"mSystems"},{"key":"446_CR18","doi-asserted-by":"publisher","first-page":"G327","DOI":"10.1152\/ajpgi.00293.2016","volume":"312","author":"RL Knoll","year":"2017","unstructured":"Knoll RL, Forslund K, Kultima JR, Meyer CU, Kullmer U, Sunagawa S, et al. Gut microbiota differs between children with inflammatory bowel disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Am J Physiol-Gastrointest Liver Physiol. 2017;312:G327\u201339. Available from. https:\/\/doi.org\/10.1152\/ajpgi.00293.2016.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"446_CR19","doi-asserted-by":"publisher","first-page":"30594","DOI":"10.1038\/srep30594","volume":"6","author":"X Liu","year":"2016","unstructured":"Liu X, Zeng B, Zhang J, Li W, Mou F, Wang H, et al. Role of the gut microbiome in modulating arthritis progression in mice. Sci Rep. 2016;6:30594. Available from. https:\/\/doi.org\/10.1038\/srep30594.","journal-title":"Sci Rep"},{"key":"446_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8:43. Available from. https:\/\/doi.org\/10.1186\/s13073-016-0299-7.","journal-title":"Genome Med"},{"issue":"6","key":"446_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1053\/j.gastro.2015.01.007","volume":"148","author":"D Lee","year":"2015","unstructured":"Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, et al. Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2015;148(6):1087\u2013106. Available from. https:\/\/doi.org\/10.1053\/j.gastro.2015.01.007.","journal-title":"Gastroenterology"},{"issue":"4","key":"446_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ajg.2011.44","volume":"106","author":"JK Hou","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563\u201373. Available from. https:\/\/doi.org\/10.1038\/ajg.2011.44.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"446_CR23","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/nu12051456","volume":"12","author":"C Gioia","year":"2020","unstructured":"Gioia C, Lucchino B, Tarsitano MG, Iannuccelli C, Di Franco M. Dietary Habits and Nutrition in Rheumatoid Arthritis: Can Diet Influence Disease Development and Clinical Manifestations? Nutrients. 2020;12(5):1456. Published 2020 May 18. Available from. https:\/\/doi.org\/10.3390\/nu12051456.","journal-title":"Nutrients"},{"issue":"1","key":"446_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1191\/1352458505ms1119oa","volume":"11","author":"S Schwarz","year":"2005","unstructured":"Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler. 2005;11(1):24\u201332. Available from. https:\/\/doi.org\/10.1191\/1352458505ms1119oa.","journal-title":"Mult Scler"},{"issue":"3","key":"446_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1586\/egh.11.29","volume":"5","author":"AC Brown","year":"2011","unstructured":"Brown AC, Rampertab SD, Mullin GE. Existing dietary guidelines for Crohn's disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2011;5(3):411\u201325. Available from. https:\/\/doi.org\/10.1586\/egh.11.29.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"446_CR26","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3748\/wjg.v22.i7.2179","volume":"22","author":"F Durchschein","year":"2016","unstructured":"Durchschein F, Petritsch W, Hammer HF. Diet therapy for inflammatory bowel diseases: the established and the new. World J Gastroenterol. 2016;22(7):2179\u201394. https:\/\/doi.org\/10.3748\/wjg.v22.i7.2179.","journal-title":"World J Gastroenterol"},{"key":"446_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDS.S6922","volume":"4","author":"L Vitetta","year":"2012","unstructured":"Vitetta L, Coulson S, Schloss B, Allen SA. Dietary recommendations for patients with rheumatoid arthritis: a review. Nutrition and Dietary Supplements. Nutr Diet Suppl. 2012;4:1\u201315. https:\/\/doi.org\/10.2147\/NDS.S6922.","journal-title":"Nutr Diet Suppl"},{"key":"446_CR28","doi-asserted-by":"publisher","unstructured":"Hansen T, Duerksen DR. Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease. Nutrients. 2018;10(5). https:\/\/doi.org\/10.3390\/nu10050537.","DOI":"10.3390\/nu10050537"},{"issue":"11","key":"446_CR29","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/nu11112657","volume":"11","author":"JM Comeche","year":"2019","unstructured":"Comeche JM, Caballero P, Gutierrez-Hervas A, et al. Enteral Nutrition in Patients with Inflammatory Bowel Disease. Systematic Review, Meta-Analysis, and Meta-Regression. Nutrients. 2019;11(11):2657. Published 2019 Nov 4. https:\/\/doi.org\/10.3390\/nu11112657.","journal-title":"Nutrients"},{"issue":"10","key":"446_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014;8(10):1179\u2013207, ISSN 1873\u20139946. https:\/\/doi.org\/10.1016\/j.crohns.2014.04.005.","journal-title":"J Crohns Colitis"},{"key":"446_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1741-7015-11-73","volume":"11","author":"J C\u00e1rdenas-Rold\u00e1n","year":"2013","unstructured":"C\u00e1rdenas-Rold\u00e1n J, Rojas-Villarraga A, Anaya JM. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013;11:73. https:\/\/doi.org\/10.1186\/1741-7015-11-73.","journal-title":"BMC Med"},{"issue":"6","key":"446_CR32","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.socscimed.2006.11.002","volume":"64","author":"AG Thompson","year":"2007","unstructured":"Thompson AG. The meaning of patient involvement and participation in health care consultations: a taxonomy. Soc Sci Med. 2007;64(6):1297\u2013310. https:\/\/doi.org\/10.1016\/j.socscimed.2006.11.002.","journal-title":"Soc Sci Med"},{"key":"446_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/bmj.a1344","volume":"11","author":"F Sofi","year":"2008","unstructured":"Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. Br Med J. 2008;11:337\u201344. https:\/\/doi.org\/10.1136\/bmj.a1344.","journal-title":"Br Med J"},{"issue":"4","key":"446_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1369-7625.2012.00783.x","volume":"17","author":"H Vaillancourt","year":"2014","unstructured":"Vaillancourt H, L\u00e9gar\u00e9 F, Lapointe A, Desch\u00eanes SM, Desroches S. Assessing patients\u2019 involvement in decision making during the nutritional consultation with a dietitian. Health Expect. 2014;17(4):545\u201354. https:\/\/doi.org\/10.1111\/j.1369-7625.2012.00783.x.","journal-title":"Health Expect"},{"issue":"1","key":"446_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1744-6198.2009.00124.x","volume":"44","author":"SM Cohen","year":"2009","unstructured":"Cohen SM. Concept analysis of adherence in the context of cardiovascular risk reduction. Nurs Forum. 2009;44(1):25\u201336. https:\/\/doi.org\/10.1111\/j.1744-6198.2009.00124.x.","journal-title":"Nurs Forum"},{"issue":"1","key":"446_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11136-013-0458-x","volume":"23","author":"P Wicks","year":"2014","unstructured":"Wicks P, Stamford J, Grootenhuis MA, Haverman L, Ahmed S. Innovations in e-health. Qual Life Res. 2014;23(1):195\u2013203. https:\/\/doi.org\/10.1007\/s11136-013-0458-x.","journal-title":"Qual Life Res"},{"key":"446_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.therap.2016.11.058","volume":"72","author":"S Ravoire","year":"2017","unstructured":"Ravoire S, Lang M, Perrin E. Advantages and limitations of online communities of patients for research on health products. Therapie. 2017;72:135\u201343. https:\/\/doi.org\/10.1016\/j.therap.2016.11.058.","journal-title":"Therapie"},{"issue":"4","key":"446_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","volume":"3","author":"A Lerner","year":"2015","unstructured":"Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2015;3(4):151\u20135. Available from. https:\/\/doi.org\/10.12691\/ijcd-3-4-8.","journal-title":"Int J Celiac Dis"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-021-00446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-021-00446-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-021-00446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T20:05:30Z","timestamp":1626379530000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnutr.biomedcentral.com\/articles\/10.1186\/s40795-021-00446-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1186\/s40795-021-00446-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-137887\/v1","asserted-by":"object"}]},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures followed for this study were in accordance with the French Law 78\u201317 of 6 January 1978 and its later amendments and the General Data Protection Regulation.The study was conducted in accordance with Good Epidemiological Practices.Our satisfaction survey (Market Research) is not qualified as a research involving the human person and does not fall within the scope of the article L1121\u20131 (\n                      \n                      ), modified by the decree n\u00b02017\u2013884 (\n                      \n                      ).Thus, the satisfaction survey is apart from any submission to a French ethic committee (Comit\u00e9 de Protection des Personnes, CPP) and to the French health authority (ANSM), as mentioned by the article L1123\u20138 (\n                      \n                      ).Informed consent was obtained from all participants. Before their inclusion in the study, all patients were informed about the aim, method and duration of the study and have consented expressly and specifically to the collection, handling and storage of their personal and health data. All participants were free to withdraw from the study at any time without notice or reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TP has received consulting\/conference fee from AbbVie, Biogen, BMS, Chugai, Gilead, Fresenius Kabi, Janssen, Lilly, Medac, MSD, Nordic Pharma, Novartis, Pfizer, Roche, Sandoz, Sanofi, UCB.HS has received consulting\/conference fee from Enterome, Ferring, Fresenius, Amgen, MSD, BMS, Takeda, Biocodex, Pfizer, Sanofi, Janssen, Astellas, Gilead, Danone, Roche, BiomX, Adare, Eligo. Co-founder of Exceliom Bioscience.BH has received consulting\/conference fee from Celgene, Leo Pharma, Lilly and Fresenius Kabi.GP and MB are Fresenius Kabi France employees.EP and DT are Carenity employees.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}